股腘动脉支架长期结局:多中心回顾及多普勒超声监测意义
该多中心回顾性队列纳入220例患者238枚股腘动脉支架,分析一期通畅率与免截肢生存。5年一期通畅率仅11.7%,CLTI、1型糖尿病和女性是通畅丢失的独立预测因素,提示高危患者或可从多普勒超声监测中获益。
要点
- 股腘动脉支架5年一期通畅率低至11.7%,长期监测与再干预策略需重视。
- CLTI、1型糖尿病和女性与一期通畅丢失独立相关,属监测重点人群。
- 药物洗脱支架和糖尿病与更差免截肢生存相关,选择器械时需权衡。
核心结论
- CLTI和糖尿病等高危股腘动脉支架患者可能从强化的多普勒超声监测项目中获益。
- 该监测项目的临床有效性、成本效益和实施可行性仍需进一步研究。
研究设计与样本
- 多中心回顾性队列研究,纳入2015年1月至2023年4月六家医院血管网络内接受股腘动脉支架的患者。
- 共分析220例患者的238枚支架,采用Cox比例风险模型和logistic回归识别预测因素,Kaplan-Meier曲线评估结局。
主要发现
- 238枚支架中女性占28.6%,中位年龄72.5±11.5岁,74.8%(178例)表现为CLTI。
- 30天、6个月、1年、3年、5年一期通畅率分别为90%、67.7%、51.2%、26.6%、11.7%。
- 平均免截肢生存为3.2年。
- 药物洗脱支架和糖尿病与更差的免截肢生存相关。
临床怎么用
- 对合并CLTI、1型糖尿病或女性的股腘动脉支架患者,应加强随访并考虑纳入多普勒超声监测。
- 药物洗脱支架和糖尿病患者需关注免截肢生存,个体化制定再干预与监测策略。
局限性
- 回顾性设计可能存在选择偏倚和混杂。
- 多普勒超声监测项目的临床有效性、成本效益和实施可行性尚未验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Peripheral arterial disease (PAD) is a significant global health concern. Endovascular revascularisation is frequently used for symptom control and limb salvage in patients with femoropopliteal PAD. However, restenosis, often necessitating re-intervention, remains a challenge. This study performs a retrospective outcomes analysis to suggest which patient populations may benefit from a Doppler ultrasound (DUS) surveillance programme in improving primary patency and amputation-free survival following femoropopliteal stenting in patients with PAD. METHODS: A multicentre, retrospective cohort study was conducted using data from patients who underwent femoropopliteal stenting between January 2015 and April 2023 within a vascular network with six hospital sites. Data were collected from 238 stents in 220 patients. Demographics, stent characteristics, and surveillance protocols were analysed. Cox proportional hazards and logistic regression models were used to identify risk factors for primary patency and amputation-free survival. Kaplan-Meier survival curves were generated for both outcomes. Descriptive statistics were used to compare outcomes between supra-popliteal and infra-popliteal stents. RESULTS: A total of 238 stents were inserted in a population comprised of 28.6% females, with the median age of 72.5 +/- 11.5 years. In 74.8% (178) of cases, patients presented with chronic limb-threatening ischaemia (CLTI). Primary patency rates at 30 days, 6 months, 1 year, 3 years, and 5 years were 90%, 67.7%, 51.2%, 26.6%, and 11.7%, respectively. The average amputation-free survival was 3.2 years. Cox regression identified CLTI (hazard ratio, 6.37, p = .001), type 1 diabetes mellitus (hazard ratio, 3.16, p = .006), and female sex (hazard ratio, 1.69, P = .037) as significant predictors of loss of primary patency. Drug-eluting stents and diabetes were associated with poorer amputation-free survival. CONCLUSIONS: The study illustrates a cohort of high-risk patients, particularly those with CLTI and diabetes, who may benefit from future enrolment in an enhanced DUS surveillance programme targeted to improve long-term outcomes. However, further research is required to explore the clinical-effectiveness, cost-effectiveness and implementation feasibility of such programmes in clinical practice.
引用
- Ho J, Roup Rosa CA, La Torre G, et al. Long-term Outcomes of Primary Femoropopliteal Stents: A Retrospective Multi-Centre Experience and the Role for a Doppler Ultrasound Surveillance Programme. Ann Vasc Surg. 2026. PMID: 42951197. doi:10.1016/j.avsg.2026.09.056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。